Bridge helix and trigger loop perturbations generate superactive RNA polymerases
© Tan et al.. 2008
Received: 12 August 2008
Accepted: 31 October 2008
Published: 2 December 2008
Skip to main content
© Tan et al.. 2008
Received: 12 August 2008
Accepted: 31 October 2008
Published: 2 December 2008
Cellular RNA polymerases are highly conserved enzymes that undergo complex conformational changes to coordinate the processing of nucleic acid substrates through the active site. Two domains in particular, the bridge helix and the trigger loop, play a key role in this mechanism by adopting different conformations at various stages of the nucleotide addition cycle. The functional relevance of these structural changes has been difficult to assess from the relatively small number of static crystal structures currently available.
Using a novel robotic approach we characterized the functional properties of 367 site-directed mutants of the Methanocaldococcus jannaschii RNA polymerase A' subunit, revealing a wide spectrum of in vitro phenotypes. We show that a surprisingly large number of single amino acid substitutions in the bridge helix, including a kink-inducing proline substitution, increase the specific activity of RNA polymerase. Other 'superactivating' substitutions are located in the adjacent base helices of the trigger loop.
The results support the hypothesis that the nucleotide addition cycle involves a kinked bridge helix conformation. The active center of RNA polymerase seems to be constrained by a network of functional interactions between the bridge helix and trigger loop that controls fundamental parameters of RNA synthesis.
RNA polymerases (RNAPs) are central components of the cellular transcriptional machineries that are targeted by numerous regulatory proteins to fine-tune the expression of genomes in a highly controlled manner. It is therefore important to study the functional properties of RNAPs in order to understand how these are modulated during the various stages of the transcription cycle.
Although the key domains involved in the translocation of the substrates through the RNAP catalytic site are thus unambiguously identified, there is still a lot of uncertainty concerning the detailed molecular events occurring in the active site during RNA synthesis. This lack of understanding is mostly due to the fact that the current models are based on a small number of 'snapshots' of relatively stable structures that can be studied after crystallization. RNAPs are, however, complex macromolecular machines that undergo multiple conformational changes during the nucleotide addition cycle, which may be too unstable and short-lived to be captured in a rigid crystal structure. We therefore decided to learn more about the functional aspects of the bridge helix/trigger loop mechanism by systematically mutating residues located in critical positions relative to the active site. We employed an archaeal RNAP model system, derived from the hyperthermophilic euryarchaeon Methanocaldococcus jannaschii, to reconstitute an active enzyme from separate recombinant subunits in vitro [22, 23]. Archaeal RNAPs are structurally and functionally very closely related to bacterial and eukaryotic RNAPIIs and thus provide an ideal experimental platform for a structure-function approach that can exploit the large body of data obtained in these mainstream experimental systems [9, 24]. The ability to reconstitute recombinant RNAPs in vitro allows targeted mutation(s) to be introduced at predetermined locations using efficient DNA cloning and protein expression technologies. This approach, in combination with recently developed robotic methods for assembling recombinant RNAPs in high-throughput format , provides the necessary tools for dissecting the functional properties of key RNAP domains at unprecedented resolution. The results obtained shed new light on the role of individual residues and provide evidence for the functional relevance of conformational changes in the active site of RNAPs that are not evident from the previously available structural and genetic data.
The bridge helix of M. jannaschii RNAP is located near the carboxyl terminus of the mjA' subunit and is clearly identifiable by its colinearity and high degree of sequence identity and/or similarity to bacterial and eukaryotic orthologs  (Figure 1b). The region chosen for the high-throughput mutagenesis approach is a stretch of 17 contiguous residues (mjA' L814 to mjA' R830 inclusive) that spans the active site (Figure 1a). We produced a library for each of these residues by creating targeted point mutations encoding all 19 possible single substitutions. The constructs encoding the mutants were expressed as recombinant subunits in Escherichia coli, purified and assembled in quadruplicate under identical conditions using the recently developed 'RNAP Factory' approach . The parallel conditions for the growth, purification and in vitro assembly of a large number of mutant subunits (typically 96) provide a remarkable degree of consistency that allows the phenotypic effect of each mutation to be quantified robustly under defined in vitro conditions . The resulting RNAP variants were initially screened using a high-throughput trichloroacetic acid (TCA) precipitation assay that measures the incorporation of [32P]rUTP into transcripts using nuclease-activated DNA as template. The bridge helix is part of the catalytic site of RNAPs, and these assays therefore provide a reliable and informative readout. We also tested a subset of mutants in separate dinucleotide extension assays that specifically measure abortive transcription events. These assays show that the effects of the various mutants on abortive transcription are comparable to the results obtained with the TCA-precipitation assays ( and LT and ROJW, unpublished results; see also Figures 2c,d and 3b).
As expected, many residues that seem to occupy critical positions in the previously published X-ray structures are particularly sensitive to change and cannot be substituted with any other amino acid without noticeable loss of activity. These include residues that interact with the rNTPs in the catalytic site (T821 in the single-letter amino acid code), or the DNA template strand entering the active site (T821, G825, Y826 and R829), thus confirming their essential roles. It is possible to deduce, for several positions in the bridge helix, the precise requirement for side-chain chemistry. This is easiest with residues for which most substitutions result in substantial loss of function. We have previously commented on the fact that for G825 the physical size of the side chain seems to be crucial because any additional atoms (other than the single hydrogen side chain of glycine) create a physical obstacle for the passing of the DNA template strand into the active site . The phenotypes of T821 substitutions also reveal a high degree of sensitivity to alteration. Because of its location in the active site, the T821 side chain is placed in a unique position where, depending on the translocation state, the residue interacts either with the 3' OH end of the nascent transcript, or with the rNTP at the insertion site. Substitutions of T821 with alternative residues containing long, charged and/or bulky side chains lead to dramatic loss of function that is almost certainly caused by steric clashes and unfavorable intermolecular interactions.
Surprisingly, other residues that seem to be in spatially constrained positions in published X-ray structures can be replaced with a chemically diverse set of side chains without substantial loss of function. Inspection of X-ray structures of elongating RNAP complexes suggests that the A822 position would be unable to accommodate large side chains owing to steric clashes with the DNA template strand (see, for example, [5, 6, 11]). Substitutions of A822 with residues containing large, bulky and/or hydrophobic side chains (for example N, Q, F or Y) cause only a modest decrease of activity as compared with the wild-type enzyme. There is also a similarly unexpected tolerance to proline substitutions in certain bridge helix positions. The imino acid proline is fundamentally incapable of participating in α-helical conformations, restricts the conformational space of the residue at its amino-terminal side and disrupts the local hydrogen bonding pattern that stabilizes the secondary structure (see, for example, ). In many positions of the bridge helix, proline substitutions cause, as expected, a large loss of activity (summarized in Additional data file 20). In other positions (for example, T821P and A822P), a clearly detectable activity remains, and in one case (S824P) we found an astonishing increase of activity of the mutant in comparison with the wild type (Figure 2a; a more extensive interpretation of this phenotype is provided below). We deduce from the proline substitution phenotypes that there is no absolute requirement, at any stage of the nucleotide addition cycle, for the bridge helix to maintain the continuous α-helical conformation that has previously been observed very consistently in structural studies of elongating RNAPs (see, for example, [6–8]).
A third class of phenotype uncovered in the high-throughput screen is an unexpected large number of mutations (about 7% of the entire set) showing increased activity. We will refer to this phenomenon as 'superactivity' because it exceeds the normal wild-type level. The substitutions causing the catalytic enhancement are predominantly clustered in the D816, Q817, V819, Q823 and S824 positions. In addition, certain substitutions of R820, A822 and M827 result in more moderately increased levels of activity. A helical wheel projection shows that the side chains of D816, Q817, V819, Q823, S824 and M827 point away from the RNAP catalytic center (Figure 2b). This leads us to conclude that superactivity is not caused by the mutated side chains stimulating events in the active site directly; the observed phenotypes must instead be due to conformational changes in the structure of the bridge helix itself, and/or to an altered interaction pattern of the bridge helix with the adjacent trigger loop domain.
Two of the residues that can be mutated to superactivity (Q823 and S824) are orthologs of Thermus thermophilus (tth) subunit β' residues D1090 and S1091. In certain bacterial RNAP structures the two residues are present in a flipped-out configuration that disrupts the local hydrogen-bonding pattern of the α-helical structure [10–12]. These studies [10–12] have shown that tthβ' D1090 (the ortholog of mjA' Q823) stabilizes the kinked conformation of the bridge helix through specific hydrogen bonding with a nearby invariant residue, tthβ' R1096  (Figures 1d and 3a). Such arginine-aspartate contacts are known to be of unusual strength, highly directional and, thus, particularly suitable for stabilizing intramolecular interactions ; there is also evidence that they can act as switches to stabilize alternative protein conformations ('ionic locks'; see, for example, ). It therefore seems that the mjA' Q823D substitution is capable of mimicking the aspartate-arginine stabilization pattern that is responsible for the kinked conformation of bacterial bridge helices. The enzyme containing Q823D is substantially more active than the wild type, suggesting that the kinked bridge helix represents a conformation that is highly favorable for the nucleotide addition cycle.
This interpretation of the Q823D phenotype receives further support from the most unusual mutant revealed in our screen. The superactive S824P substitution is also predicted to cause a kinked bridge helix conformation. When present in an α helix, proline residues distort the helical structure by consistently introducing a highly localized and permanent kink of about 26° . Our results show that the placement of proline residues in the bridge helix sequence needs to be very precise to achieve this effect because proline substitutions in most other positions cause substantial, or even total, loss of activity (Figure 2a; Additional data file 20).
Increased levels of transcription can be the result of decreased abortive transcription rates favoring promoter clearance . Dinucleotide extension assays confirmed, however, that the increased catalytic activities of the superactive mutants were reflected by comparable increases in abortive transcription. Under these conditions the RNAPs harboring Q823D and S824P have activities of about 135% and about 210%, respectively, relative to the wild-type enzyme (Figure 2c). The results show that the extent of kinking of the bridge helix predicted to be induced by Q823D and S824P does not seem to interfere in any way with the proposed template scrunching mechanism [31, 32]. In addition, we investigated the elongation properties of the mutant RNAPs using factor-independent nucleic acid scaffolds under conditions allowing repeated initiation [23, 33]. The results are directly comparable to the activities shown in the abortive transcription assays (Figure 2d). It is therefore clear that the superactive phenotypes are consistently observed in a variety of transcription assays. In comparison with the wild-type enzyme, superactive mutants assemble with equal efficiency, show identical chromatographic elution patterns and the same degree of thermostability (Additional data files 18 and 19; ROJW, unpublished data). The increased production of transcripts is thus solely a consequence of the enhanced catalytic activity, and it demonstrates that mutations in the bridge helix modulate the active site in a direct and rate-determining manner. In preliminary studies we tested the wild-type enzyme and RNAPs containing the superactive bridge helix substitutions for misincorporation of dTTP in non-specific, abortive and elongation assays and have so far found no detectable loss of selectivity in rNTP incorporation (data not shown).
The conclusions from two independently acquired pieces of evidence thus converge on the same explanation: the superactive mutations Q823D and S824P are capable of creating and/or stabilizing a localized kink in a precisely defined region of the bridge helix. Because these mutations seem to achieve a similar result using different structural principles, we investigated the effects of double mutant combinations. Constructs containing Q823 and S824 substitutions in combinatorial configurations were used to create Q823D/S824M, Q823D/S824P, Q823E/S824M and Q823E/S824P double mutants. The double mutants showed similar levels of elevated activity as Q823D and S824P on their own, demonstrating that no further gain of function is achievable (Figure 2c,d; Additional data file 19).
A final piece of evidence in support of an interaction between Q823 and R829 comes from a stringent test using another set of double mutants. Taking into account the stabilizing interactions between tthβ' D1090 and tthβ' R1096  (Figure 3a), we wondered whether it would be feasible to recreate this interaction by switching the positions of these residues. Although a Q823R/R829D double substitution was inactive, another, Q823H/R829D, had 47–50% of wild-type activity (Figure 3b,c). We consider this result to be remarkable, taking into account the fact that R829D is completely inactive (like any other substitution in that position except, to a certain extent, lysine; Figure 3b). The presence of a histidine residue in position 823 thus rescues, to a significant extent, the R829D phenotype in a manner consistent with the predicted local interaction between these two positions during bridge helix kinking.
Each of the superactive point mutants is capable of causing the phenotype to the fullest possible extent on its own, and the absence of additive or synergistic effects is compatible with the view that the mutants kink the bridge helix in a similar manner. Structural evidence for bridge helix kinking was previously observed only in bacterial RNAPs [10–12]. The data presented here reveal for the first time a common link between the hitherto distinct bridge helix conformations in bacterial and archaeal RNAPs. Given that archaeal bridge helices are more akin to their eukaryotic counterparts than are the bacterial bridge helices, a plausible implication of this argument is that localized bridge helix kinking forms part of the normal RNAP nucleotide addition cycle across the entire evolutionary range.
The spatial vicinity between the bridge helix residues and trigger loop base helix residues prompted us to investigate the possible significance of these contacts in more detail. Residues orthologous to mjA' Q823 touch a specific residue in the carboxy-terminal trigger loop base helix (abbreviated as TLC from here on) that corresponds to residue I98 of the RNAP mjA'' subunit. Conversely, residues orthologous to S824 touch another residue in the amino-terminal trigger loop base helix (TLN), which corresponds to mjA'' G72 (Figure 4c). Given the geometry of α helices (which imposes an angle of about 100° between adjacent amino acids), the bridge helix is thus capable of contacting both trigger loop base helices using only two successive residues. The contacts of Q823 and S824 with TLC and TLN, respectively, could constitute an important functional interface between the bridge helix and trigger loop. We therefore created two more libraries containing all possible substitutions in mjA'' G72 and mjA'' I98, respectively, to study the phenotypic effects.
This investigation reveals that the mjA'' I98 (TLC) position is intrinsically weakly stable and becomes easily disordered when substituted by almost all residues identified in the trigger loop mutagenesis screen that convert the RNAP to superactivity (Figure 5b). The presence of a highly conserved G-X-P hinge motif  nearby may be important in this conformational switch. A similar study classifies the region surrounding G72 as unstable (Additional data file 21). We therefore propose that the trigger loop base helices TLN and TLC are finely poised at the edge of structural stability. Even minor variations (such as the replacement of either mjA'' G72 or mjA'' I98 with other residues by site-directed mutagenesis) cause a substantial loss of local stability by altering the local net charge/hydrophobicity ratio. In bacterial RNAPs, TLN and TLC are capable of adopting alternative conformations, possibly in response to structural changes in the hinge region of the bridge helix . Similarly, in yeast RNAPII the scRpb1 E1103G substitution (corresponding to mjA''E99, that is, immediately carboxy-terminal to the mjA'' I98 in TLC; Figure 4) shows increased catalytic activity [21, 34, 38]. These results provide a plausible explanation for the superactive phenotypes observed with certain substitutions in bridge helix residues. Some of the mutations in Q823 and S824 destabilize TLN and TLC by kinking this part of the bridge helix away from the trigger loop base helices, thus causing conformational changes in the trigger loop that increase the catalytic activity (Figure 4b). We also imagine that similar events are likely to occur in the superactive mutations located in more amino-terminal regions of the bridge helix, such as D816, Q817 and V819. The precise contact points between the bridge helix and trigger loop in these regions are, however, not as clearly definable because different trigger loop orientations have been observed in RNAP crystal structures [7, 8, 12].
Finally we created various recombinant RNAPs containing combinations of superactive bridge helix and superactive trigger loop mutants, such as mjA' S824P/mjA'' I98P. Just as previously observed with the bridge helix double mutants, no further increase in superactivity was detected (data not shown). Single point mutants in either the bridge helix or the trigger loop are therefore sufficient to induce the full superactivity phenotype. The lack of additivity or synergism suggests that each mutant affects the same process in a functionally overlapping and mutually independent manner.
Although the chemical aspects of the catalytic functions of nucleic acid polymerases are well established , there is still a considerable amount of uncertainty concerning the mechanical aspects that link these catalytic steps to movement of the nucleic acid substrates through the active site.
In this study we describe the most extensive example of a high-throughput structure-function analysis so far that relies on neither genetic screens to isolate mutants nor the use of site-directed mutagenesis to test a preconceived model. Instead, we implemented a new experimental approach that is designed to sample systematically a substantial area of protein structure-function space. The collection of such large datasets is especially important for complex macro-molecular machines that undergo substantial conformational changes at different stages of the reaction cycle that might not be obvious from the small numbers of 'canonical' high-resolution structures available . Many of the most informative mutants discovered in the screen would not have been designed using prior knowledge, either because there would have been no rational reason to do so (for example, V818K), or because the likelihood of obtaining useful insights would have been regarded as too low to justify the experimental effort (for example, S824P).
The results shed new light on the mutual relationship between the bridge helix and trigger loop. Specifically, we show that the molecular contacts made between the bridge helix and trigger loop are influenced by the conformations of the two domains (localized kinking of the bridge helix and stability of the trigger loop base helices). The preponderance of the straight bridge helix conformation in the majority of available structures has resulted in the kinked versions often being dismissed as artifacts or 'off-pathway' conformations. Results shown here prove that kinked bridge helix conformations are indeed compatible with catalytic function and even capable of supporting rates that exceed wild-type activity by a considerable measure. We suggest that bridge helix kinking is a normal (although possibly short-lived) intermediate conformational state of RNAP and that the enhanced catalytic rates observed in some of the mutants are the result of a bias towards this state. Such an interpretation is in general agreement with the original models proposed for RNAP function [5, 6, 8, 14, 17], rather than more recent trigger loop-centric hypotheses [3, 18].
The more amino-terminal bridge helix mutants (for example, V819K, Q817T and D816N) probably act in a similar manner by weakening trigger loop contacts in the region closer to the active site, but they may also exert their effects more indirectly through as yet undefined local changes in bridge helix folding and stability (Additional data file 21). We therefore propose that the flexibility of the trigger loop is directly influenced by the conformation of the bridge helix. Any loss of this bridge-helix-induced constraint on the trigger loop allows the trigger loop to remain longer in a conformation favorable to catalysis and thus give rise to the superactive phenotypes observed.
We further suggest that under normal conditions a periodic transition between the straight and kinked version of the bridge helix allows the trigger loop to take up temporarily a conformation that is highly favorable for the execution of the catalytic reaction before it becomes restrained again through contacts along the bridge helix/trigger loop interface. Normal wild-type activity may therefore be the consequence of temporary bursts of catalytic activity, which are more prolonged in the superactive mutants described here. We currently do not understand how the trigger loop interacts with the catalytic site to promote phosphodiester bond formation, but it is feasible that a kinked bridge helix conformation stabilizes the post-translocation state of the DNA-RNA hybrid and thus provides the trigger loop tip domain with an increased opportunity to sequester an incoming rNTP in a steric manner most favorable for phosphodiester bond formation [7, 8, 18, 34]. A recent report also suggests that bridge helix kinks could facilitate the conformation of the pre-insertion position of the DNA template strand; such a phenomenon could also explain, at least in part, the increased level of activity in some of the bridge helix mutants described above .
The high-throughput mutagenesis data show that the bridge helix of M. jannaschii RNAP subunit mjA', in combination with the trigger loop, has a major impact on the catalytic activity of RNAP. The extent of this effect is striking: single point mutants in these domains cause functional effects that range from complete abolition of enzyme function to a near-doubling of the catalytic rate without any additional changes anywhere else among the up to 3,500 other amino acids that make up a complete multisubunit RNAP. Although our results are currently restricted to an archaeal in vitro system, it is very likely that many of the features described here are universal, and we expect that it will be possible to create bridge helix mutants with similar properties in other well-studied organisms, such as E. coli and Saccharomyces cerevisiae. Furthermore, the variations displayed by the superactive mutations in the bridge helix/trigger loop domains prove that the catalytic rate of RNAPs is intrinsically subject to variation and is, at least under in vitro conditions, not programmed to its maximum level. Interactions with regulatory proteins (especially elongation and anti-termination factors) can modulate the active site by stabilizing different conformational states (Figure 6), and evolutionary changes in the bridge helix and trigger loop sequences can 'fine tune' the catalytic capacity of cellular enzymes for an optimum rate in the long term.
It has previously been suggested that in prokaryotes the RNAP elongation rate may be optimized for allowing RNA folding or co-translation and in eukaryotes for post-transcriptional processing of primary transcripts [43–45]. Inspection of the amino acids present in certain rate-determining bridge helix positions shows an intriguing degree of species-dependent variation (Figures 1b and 4c; Additional data files 1-17), which suggests that such adaptations are indeed used during evolution to continuously coordinate the functional properties of RNAPs with other processes involved in gene expression.
The generation of site-directed mutants using oligonucleotides with randomized codon positions (mjA'A818, V819, R820, T821, A822, Q823, S824, G825, Y826, M827, Q828, R829 and R830) was carried out as described in Nottebaum et al. . Briefly, the segment of bacterial expression vectors encoding the bridge helix domain was replaced with double-stranded oligonucleotides containing randomized positions corresponding to the codon targeted for muta-genesis. Constructs containing the desired amino acid substitutions were selected from a collection of randomly picked clones after sequencing. For residues mjA' L814, V815, D816, Q817 and mjA'' G72 and I98, sequential permutation libraries were constructed from custom synthetic libraries purchased from GeneArt (Regensburg, Germany). Each mutant construct described in this study was validated at least once by DNA sequencing to confirm the presence of the expected point mutation and the integrity of the restriction enzyme sites used for the subcloning procedures.
The expression plasmids were stored as arrayed frozen bacterial expression strain stocks in two-dimensionally barcoded tubes at -80°C in the presence of 5% dimethyl sulfoxide as anti-freezing agent. For each mutagenized amino acid position, all substitutions were arranged in a standardized pattern with multiple wild-type and negative controls. For recombinant protein production, four 24-deepwell plates containing 1.5 ml per well of autoinduction medium (Novagen) were robotically inoculated from these frozen stocks and grown with shaking at 37°C for 16 h before further processing.
The purification of mutant and wild-type mjA' subunits was carried out robotically in sets of 96 as described previously . Briefly, aliquots of the induced cultures were lyzed in deepwell plates using chemical and enzymatic agents [FastBreak (Promega) and Lysonase (Novagen), respectively]. The recombinant mjA' subunits were then purified from the lysates as inclusion bodies and solubilized in the presence of near-saturating (8.3 M) urea. The protein concentrations of the subunit preparations were automatically monitored with the Bicinchonic Acid assay (Sigma). A similar procedure was adapted for the purification of recombinant mjA'' subunits by including 10% isopropanol in the wash buffer to reduce the solubility of the recombinant proteins during the inclusion body purification step. This procedure typically yielded about 250 μg of purified recombinant subunits from 900 μl expression culture with a standard deviation in the concentrations of individual subunit preparations of less than ± 10% (the presence of the point mutations had no discernible effect on the growth of expression cultures or on the yield and solubility of the recombinant proteins).
The assembly procedure was carried out robotically as previously described . Small-scale in vitro assembly reactions (final volume 100 μl) were robotically prepared by combining aliquots of the mjA' mutant subunits with a 'Master Mix (-A')' containing an empirically optimized mixture of the other RNAP subunits in 6 M urea (the subunits present in the Master Mix are rate-limiting in the assembly reactions; variations in the mutant mjA' subunit concentrations thus do not influence the final yield of assembled RNAP). The assembly mixtures were then transferred to a 96-well microdialysis device (Spectrum Laboratories). The RNAPs were automatically assembled by gradually lowering the urea concentration in the dialysis chamber from 6 M to urea-free over a period of 16 h using a robotically controlled pump. For chromatographic analyses (Additional data file 18), 350 μl assembly mixes were separated on a Superose-12 10/300 High Performance column (GE Healthcare) on a BioLogic Duoflow system (Bio-Rad) at a flow rate of 0.25 ml/minute in urea-free assembly buffer . The eluate was monitored with a Quad-Tech detector (Bio-Rad) and fractions collected (350 μl each) were analyzed for RNAP activity using the automated TCA precipitation assay described below.
TCA precipitation assays measuring the incorporation of [α-32P]rUTP into TCA-insoluble products were carried out as previously described [22, 23]. For the robotic implementation of this assay , aliquots of the assay mixtures were incubated for 45 minutes at 70°C in thin-wall PCR plates. The radiolabeled transcripts were then precipitated by the addition of ice-cold TCA solution. After incubation for 30 minutes at 1°C, the mixture was robotically pipetted onto a 96-GF/F glass fiber filter plate (Whatman) on a robotic vacuum platform. Unincorporated [α-32P]rUTP was filtered to waste and the labeled RNA retained on the filter surface was washed seven times with further aliquots of ice-cold TCA. After additional washes with 2-propanol and vacuum drying, the amount of incorporated [α-32P]rUTP was quantified with a microplate counter (TopCount NXT, Packard) in the presence of scintillant (MicroScint-O; Perkin-Elmer).
The dinucleotide extension (abortive) assays were performed manually as previously described . RNAPs were incubated at 70°C for 30 minutes with activated DNA (Sigma Type XV), CpG dinucleotide and [α-32P]rUTP. The extension products were separated from unincorporated label on 20% acrylamide gels, visualized by phosphoimaging (Fuji) and quantified (AIDA image analyzer; Raytest). The multiple-round elongation assays used a promoter-independent nucleic acid scaffold (EC3) that mimics an elongation transcription complex . This scaffold contains a nine-nucleotide RNA pre-hybridized to the template strand, which is extended into a 71-nucleotide run-off transcript by RNAP (in the absence of basal transcription factors). Elongation reactions were preincubated for 20 minutes at 60°C in 20 μl TB (50 mM Tris-HCl, pH 7.5, 75 mM KCl, 2.5 mM MgCl2, 10 mM dithiothreitol, 8 pmol annealed ECR3 scaffold  and about 100 ng RNAP) before transcription (20 minutes at 60°C) was initiated by the addition of NTPs [500 μM rATP, 500 μM rCTP, 500 μM rGTP, 10 μM rUTP and 0.15 MBq [α-32P]rUTP (110 TBq/mmol)]. The analysis and quantification of the extension products was carried out as described above for the dinucleotide extension assay. For all transcription assays the incubation periods were in the linear response range.
The following additional data are available. Additional data file 1 shows the structure, evolution and function of mjA' L814. Additional data file 2 shows the structure, evolution and function of mjA' V815. Additional data file 3 shows the structure, evolution and function of mjA' D816. Additional data file 4 shows the structure, evolution and function of mjA' Q817. Additional data file 5 shows the structure, evolution and function of mjA' A818. Additional data file 6 shows the structure, evolution and function of mjA' V819. Additional data file 7 shows the structure, evolution and function of mjA' R820. Additional data file 8 shows the structure, evolution and function of mjA' T821. Additional data file 9 shows the structure, evolution and function of mjA' A822. Additional data file 10 shows the structure, evolution and function of mjA' Q823. Additional data file 11 shows the structure, evolution and function of mjA' S824. Additional data file 12 shows the structure, evolution and function of mjA' G825. Additional data file 13 shows the structure, evolution and function of mjA' Y826. Additional data file 14 shows the structure, evolution and function of mjA' M827. Additional data file 15 shows the structure, evolution and function of mjA' Q828. Additional data file 16 shows the structure, evolution and function of mjA' R829. Additional data file 17 shows the structure, evolution and function of mjA' R830. Additional data file 18 shows the chromatographic elution profiles of wild-type and mutant mjRNAPs. Additional data file 19 shows the activities of wild-type and mutant mjRNAPs at limiting and saturating template DNA concentrations. Additional data file 20 shows the functional consequences of proline substitutions in different bridge helix positions. Additional data file 21 contains the bioinformatic analysis of intrinsic folding properties of bridge helices and trigger loops.
The work described here was funded by grants to ROJW (BBSRC: BB/E000975/1 and BB/D5230001/1; with additional contributions from MRC G0501703 and Wellcome Trust 078043/Z/05/Z). We thank Kelvin Lam and Liu Chang for help with the cloning of some of the mutants and our colleagues (especially Peter Brick and Finn Werner) for their comments on the manuscript.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.